ATTENTION DEFICIT/HYPERACTIVITY DISORDER side effect
What is ATTENTION DEFICIT/HYPERACTIVITY DISORDER ?Drugs associated with ATTENTION DEFICIT/HYPERACTIVITY DISORDER
ACCUTANE BARACLUDE BRETHINE BUPROPION CHANTIX DIAZEPAM DILANTIN DURAGESIC EPILIM FLOVENT GEODON KEPPRA KLONOPIN LIPITOR LYRICA METHADONE METHYLPHENIDATE MIRAPEX NEURONTIN OXYCONTIN PAXIL RABEPRAZOLE SEROQUEL SIBUTRAMINE SINGULAIR STRATTERA TERBUTALINE TRIAMINIC VALPROATE VYVANSE WELLBUTRIN ZOLOFTATTENTION DEFICIT/HYPERACTIVITY DISORDER : Chantix Side Effects Report #5676250-3
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Mar 10, 2008. Male patient, 44 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, performance status decreased, . CHANTIX dosage: unknown. During the same period patient was treated with STRATTERA, METHYLPHENIDATE, REQUIP. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Paxil Side Effects Report #5678982-X
PAXIL problem was reported by a Health Professional from UNITED STATES on Mar 12, 2008. Male patient was diagnosed with depression, heart disease congenital and was treated with PAXIL. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, cardiac failure, developmental delay, heart disease congenital, transposition of the great vessels, ventricular septal defect, . PAXIL dosage: 20MG PER DAY. During the same period patient was treated with LASIX, IRON SUPPLEMENT, VITAMIN B SUPPLEMENT. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Singulair Side Effects Report #5690593-9
Consumer or non-health professional from UNITED STATES reported SINGULAIR problem on Mar 31, 2008. Female patient, child 11 years of age, weighting 90.00 lb, was treated with SINGULAIR. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, depression, ill-defined disorder, morbid thoughts, social avoidant behaviour, . SINGULAIR dosage: unknown. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Neurontin Side Effects Report #5620775-3
NEURONTIN problem was reported by a Health Professional from UNITED STATES on Jan 28, 2008. Male patient, weighting 208.4 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with NEURONTIN. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, nervousness, somnolence, swelling face, . NEURONTIN dosage: unknown. During the same period patient was treated with ADDERALL, SEROQUEL, LAMICTAL, LOPRESSOR, KLONOPIN. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Paxil Side Effects Report #5624661-4
Pharmacist from UNITED STATES reported PAXIL problem on Jan 31, 2008. Female patient was diagnosed with depression, heart disease congenital and was treated with PAXIL. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, developmental delay, heart disease congenital, transposition of the great vessels, ventricular septal defect, . PAXIL dosage: 20MG PER DAY. During the same period patient was treated with LASIX, IRON SUPPLEMENT, VITAMIN B SUPPLEMENT, PRENATAL VITAMINS. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Duragesic Side Effects Report #5627332-3
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2008. Female patient, weighting 130.0 lb, was diagnosed with pain, attention deficit/hyperactivity disorder, bipolar disorder and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, depression, diarrhoea, hyperhidrosis, hysterectomy, mood swings, urinary tract infection, vomiting, . DURAGESIC dosage: unknown. During the same period patient was treated with PREMARIN, CONCERTA, CLOZAPINE, SEROQUEL, EFFEXOR. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Methylphenidate Side Effects Report #5642578-6
Health Professional from UNITED STATES reported METHYLPHENIDATE problem on Feb 27, 2008. Female patient, weighting 138.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, educational problem, no therapeutic response, . METHYLPHENIDATE dosage: 20MG ONE PO DAILY. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Baraclude Side Effects Report #5602728-4
BARACLUDE problem was reported by a Health Professional from GERMANY on Jan 23, 2008. Male patient, 20 years of age, weighting 145.5 lb, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, convulsion, . BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Paxil Side Effects Report #5551082-5
Consumer or non-health professional from UNITED STATES reported PAXIL problem on Dec 03, 2007. Female patient was diagnosed with depression, heart disease congenital and was treated with PAXIL. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, developmental delay, heart disease congenital, transposition of the great vessels, ventricular septal defect, . PAXIL dosage: 20MG PER DAY. During the same period patient was treated with LASIX, IRON SUPPLEMENT, VITAMIN B SUPPLEMENT, PRENATAL VITAMINS. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Terbutaline Side Effects Report #5557085-9
TERBUTALINE SULPHATE problem was reported by a Health Professional from UNITED STATES on Dec 11, 2007. Male patient, weighting 7.50 lb, was diagnosed with premature labour and was treated with TERBUTALINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, . TERBUTALINE SULPHATE dosage: 2.5 MG Q4 PO. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Triaminic Side Effects Report #5567688-3
Consumer or non-health professional from UNITED STATES reported TRIAMINIC SRT problem on Dec 08, 2007. Male patient, 23 years of age, was treated with TRIAMINIC SRT. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, impaired work ability, nervous system disorder, personality disorder, schizophrenia, suicidal ideation, . TRIAMINIC SRT dosage: unknown. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Epilim Side Effects Report #5576478-7
EPILIM problem was reported by a Consumer or non-health professional from FRANCE on Dec 19, 2007. Male patient was treated with EPILIM. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, disturbance in social behaviour, dyslexia, dysmorphism, dyspraxia, foetal anticonvulsant syndrome, hypokinesia, learning disorder, speech disorder, . EPILIM dosage: unknown. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Geodon Side Effects Report #5505702-1
Consumer or non-health professional from UNITED STATES reported GEODON problem on Oct 22, 2007. Female patient, child 10 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with GEODON. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, fatigue, hallucination, auditory, movement disorder, muscle disorder, tic, . GEODON dosage: DAILY DOSE:120MG. During the same period patient was treated with LISDEXAMFETAMINE DIMESYLATE. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Baraclude Side Effects Report #5525781-5
BARACLUDE problem was reported by a Health Professional from GERMANY on Nov 19, 2007. Male patient, 20 years of age, weighting 145.5 lb, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, convulsion, . BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Bupropion Side Effects Report #5491904-X
Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Oct 19, 2007. Male patient, 39 years of age, weighting 175.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, condition aggravated, depression, irritability, . BUPROPION dosage: 100MG 2XDAILY PO. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Seroquel Side Effects Report #5457032-4
SEROQUEL problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2006. Female patient was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, clumsiness, constipation, dizziness, dry mouth, logorrhoea, mood swings, orthostatic hypotension, pharyngitis, . SEROQUEL dosage: unknown. During the same period patient was treated with EFFEXOR. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Dilantin Side Effects Report #5466107-5
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on Sept 13, 2007. Male patient, weighting 70.11 lb, was diagnosed with convulsion, streptococcal infection, hypertension and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, brain damage, depression, dysphagia, emotional disorder, feeding disorder, gastrointestinal disorder, lung injury, . DILANTIN dosage: unknown. During the same period patient was treated with AMPICILLIN, NORVASC. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Diazepam Side Effects Report #5406950-1
DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 19, 2007. Female patient was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, developmental delay, nystagmus, visual acuity reduced, . DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Paxil Side Effects Report #5410544-1
Consumer or non-health professional from UNITED STATES reported PAXIL problem on May 09, 2007. Male patient, child 6 years of age, was diagnosed with post-traumatic stress disorder, depression, epilepsy and was treated with PAXIL. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, . PAXIL dosage: 40MG PER DAY. During the same period patient was treated with PAROXETINE HYDROCHLORIDE, PHENOBARBITAL, XANAX. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Brethine Side Effects Report #5427497-2
BRETHINE problem was reported by a Health Professional from UNITED STATES on Aug 24, 2007. Male patient, weighting 6.60 lb, was diagnosed with premature labour and was treated with BRETHINE. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, body height below normal, educational problem, social problem, . BRETHINE dosage: 5 MG TAB EVERY 4-6 HOURS OTHER. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Diazepam Side Effects Report #5381845-0
Physician from UNITED KINGDOM reported DIAZEPAM problem on June 28, 2007. Female patient was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, developmental delay, nystagmus, . DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Methadone Side Effects Report #5387486-3
METHADONE problem was reported by a Physician from UNITED KINGDOM on June 29, 2007. Female patient was treated with METHADONE. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, developmental delay, nystagmus, . METHADONE dosage: unknown. During the same period patient was treated with DIAZEPAM. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Methadone Side Effects Report #5390655-X
Consumer or non-health professional from reported METHADONE problem on July 12, 2007. Female patient was treated with METHADONE. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, congenital nystagmus, developmental delay, posture abnormal, visual acuity reduced, . METHADONE dosage: unknown. During the same period patient was treated with DIAZEPAM. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Diazepam Side Effects Report #5402833-1
DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 19, 2007. Female patient, child 8 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, developmental delay, nystagmus, posture abnormal, visual acuity reduced, . DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Diazepam Side Effects Report #5381845-0
Physician from UNITED KINGDOM reported DIAZEPAM problem on June 28, 2007. Female patient was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, developmental delay, nystagmus, . DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Methadone Side Effects Report #5387486-3
METHADONE problem was reported by a Physician from UNITED KINGDOM on June 29, 2007. Female patient was treated with METHADONE. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, developmental delay, nystagmus, . METHADONE dosage: unknown. During the same period patient was treated with DIAZEPAM. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Methadone Side Effects Report #5390655-X
Consumer or non-health professional from reported METHADONE problem on July 12, 2007. Female patient was treated with METHADONE. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, congenital nystagmus, developmental delay, posture abnormal, visual acuity reduced, . METHADONE dosage: unknown. During the same period patient was treated with DIAZEPAM. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Diazepam Side Effects Report #5402833-1
DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 19, 2007. Female patient, child 8 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, developmental delay, nystagmus, posture abnormal, visual acuity reduced, . DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Seroquel Side Effects Report #5662583-3
Consumer or non-health professional from UNITED STATES reported SEROQUEL problem on Mar 10, 2008. Male patient, 42 years of age, weighting 175.0 lb, was diagnosed with major depression and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: amnesia, attention deficit/hyperactivity disorder, brain injury, cerebrovascular accident, compulsions, depression suicidal, incorrect dose administered, suicide attempt, . SEROQUEL dosage: unknown. During the same period patient was treated with RESPIRDOL, ABILIFY, TEGRETOL, DEPAKOTE, GABAPENTIN, BUSPAR. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Singulair Side Effects Report #5688278-8
SINGULAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2008. Male patient, 14 years of age, weighting 95.00 lb, was diagnosed with multiple allergies and was treated with SINGULAIR. After drug was administered, patient experienced the following problems/side effects: anger, attention deficit/hyperactivity disorder, depression, fatigue, irritability, malaise, mood swings, sleep disorder, somnolence, . SINGULAIR dosage: unknown. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Singulair Side Effects Report #5690299-6
Health Professional from UNITED STATES reported SINGULAIR problem on Mar 31, 2008. Male patient, weighting 89.00 lb, was diagnosed with asthma, multiple allergies and was treated with SINGULAIR. After drug was administered, patient experienced the following problems/side effects: anger, attention deficit/hyperactivity disorder, psychotic disorder, tourette's disorder, . SINGULAIR dosage: 5MG DAILY PO. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Singulair Side Effects Report #5690628-3
SINGULAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2008. Female patient, 15 years of age, weighting 145.0 lb, was diagnosed with asthma and was treated with SINGULAIR. After drug was administered, patient experienced the following problems/side effects: anxiety, attention deficit/hyperactivity disorder, convulsion, depression, intentional self-injury, limb injury, overdose, pain, suicide attempt, . SINGULAIR dosage: 10 MG 1 TAB DAILY PO. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Mirapex Side Effects Report #5620517-1
Consumer or non-health professional from UNITED STATES reported MIRAPEX problem on Jan 08, 2008. Male patient was diagnosed with restless legs syndrome, hyperlipidaemia, arthralgia, tendonitis, hypertension and was treated with MIRAPEX. After drug was administered, patient experienced the following problems/side effects: anxiety, attention deficit/hyperactivity disorder, blood cholesterol increased, convulsion, depression, emotional distress, fall, fear, hyperphagia, . MIRAPEX dosage: unknown. During the same period patient was treated with LIPITOR, BEXTRA, CANNABIS, DIOVAN HCT. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Klonopin Side Effects Report #5535777-5
KLONOPIN problem was reported by a Health Professional from UNITED STATES on Dec 04, 2007. Female patient, 36 years of age, weighting 180.0 lb, was diagnosed with anxiety, insomnia and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: anxiety, attention deficit/hyperactivity disorder, disturbance in attention, emotional disorder, fear, malaise, paranoia, pharmaceutical product counterfeit, . KLONOPIN dosage: .5MG 1X @ BEDTIME PO. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Rabeprazole Side Effects Report #5565822-2
Health Professional from UNITED STATES reported RABEPRAZOLE problem on Nov 28, 2007. Female patient, 55 years of age, was diagnosed with abdominal pain upper, dyspepsia, flatulence and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: anxiety, attention deficit/hyperactivity disorder, confusional state, erosive duodenitis, gastrooesophageal reflux disease, helicobacter gastritis, panic attack, sleep terror, . RABEPRAZOLE dosage: 20 MG, IN THE MORNING, ORAL. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Lipitor Side Effects Report #5577114-6
LIPITOR problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2007. Male patient was diagnosed with blood cholesterol and was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: amnesia, attention deficit/hyperactivity disorder, cognitive disorder, coronary artery disease, depression, disorientation, muscle spasms, myopathy, neuropathy peripheral, . LIPITOR dosage: unknown. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Vyvanse Side Effects Report #5597264-8
Consumer or non-health professional from UNITED STATES reported VYVANSE problem on Sept 20, 2007. Female patient, child 4 years of age, was treated with VYVANSE. After drug was administered, patient experienced the following problems/side effects: affect lability, attention deficit/hyperactivity disorder, off label use, . VYVANSE dosage: unknown. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Accutane Side Effects Report #5505042-0
ACCUTANE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 26, 2007. Male patient, 22 years of age, weighting 136.9 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: appendicitis, attention deficit/hyperactivity disorder, bipolar ii disorder, colitis, colitis ulcerative, crohn's disease, depression, inflammatory bowel disease, intestinal obstruction, . ACCUTANE dosage: unknown. During the same period patient was treated with HYTONE, BLISTEX. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Zoloft Side Effects Report #5530250-2
Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on Nov 27, 2007. Male patient, weighting 72.00 lb, was diagnosed with anxiety and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anxiety, attention deficit/hyperactivity disorder, no therapeutic response, psychomotor hyperactivity, sleep disorder, . ZOLOFT dosage: 12.5 MG ONCE A DAY PO. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Mirapex Side Effects Report #5474508-4
MIRAPEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2007. Male patient was diagnosed with restless legs syndrome, hyperlipidaemia, arthralgia, tendonitis, hypertension and was treated with MIRAPEX. After drug was administered, patient experienced the following problems/side effects: anxiety, attention deficit/hyperactivity disorder, blood cholesterol increased, convulsion, depression, emotional distress, fall, fear, hyperphagia, . MIRAPEX dosage: unknown. During the same period patient was treated with LIPITOR, BEXTRA, CANNABIS, DIOVAN HCT. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Accutane Side Effects Report #5479540-2
Consumer or non-health professional from UNITED STATES reported ACCUTANE problem on Sept 26, 2007. Male patient, 22 years of age, weighting 136.9 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: appendicitis, attention deficit/hyperactivity disorder, bipolar ii disorder, colitis, colitis ulcerative, crohn's disease, depression, inflammatory bowel disease, intestinal obstruction, . ACCUTANE dosage: unknown. During the same period patient was treated with HYTONE, BLISTEX. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Lipitor Side Effects Report #5491041-4
LIPITOR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2007. Male patient was diagnosed with blood cholesterol and was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: amnesia, attention deficit/hyperactivity disorder, cognitive disorder, coronary artery disease, depression, disorientation, mood swings, muscle spasms, myopathy, . LIPITOR dosage: unknown. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Geodon Side Effects Report #5491208-5
Consumer or non-health professional from UNITED STATES reported GEODON problem on Oct 10, 2007. Male patient was diagnosed with bipolar disorder, attention deficit/hyperactivity disorder, schizoaffective disorder and was treated with GEODON. After drug was administered, patient experienced the following problems/side effects: asthma, attention deficit/hyperactivity disorder, bipolar disorder, catatonia, loss of consciousness, schizoaffective disorder, . GEODON dosage: unknown. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Mirapex Side Effects Report #5498134-6
MIRAPEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Male patient was diagnosed with restless legs syndrome, hyperlipidaemia, arthralgia, tendonitis, hypertension and was treated with MIRAPEX. After drug was administered, patient experienced the following problems/side effects: anxiety, attention deficit/hyperactivity disorder, blood cholesterol increased, convulsion, depression, emotional distress, fall, fear, hyperphagia, . MIRAPEX dosage: unknown. During the same period patient was treated with LIPITOR, BEXTRA, CANNABIS, DIOVAN HCT. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Accutane Side Effects Report #5447703-8
Consumer or non-health professional from UNITED STATES reported ACCUTANE problem on Aug 29, 2007. Male patient, 22 years of age, weighting 136.9 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: appendicitis, attention deficit/hyperactivity disorder, bipolar ii disorder, colitis, colitis ulcerative, crohn's disease, inflammatory bowel disease, intestinal obstruction, oesophagitis, . ACCUTANE dosage: unknown. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Dilantin Side Effects Report #5447812-3
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2007. Male patient was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: aspiration, attention deficit/hyperactivity disorder, brain damage, corneal opacity, depression, dysphagia, emotional disorder, feeding disorder, . DILANTIN dosage: unknown. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Accutane Side Effects Report #5451468-3
Consumer or non-health professional from UNITED STATES reported ACCUTANE problem on Aug 30, 2007. Male patient, 22 years of age, weighting 136.9 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: appendicitis, attention deficit/hyperactivity disorder, bipolar ii disorder, colitis, colitis ulcerative, crohn's disease, depression, inflammatory bowel disease, intestinal obstruction, . ACCUTANE dosage: unknown. During the same period patient was treated with HYTONE, BLISTEX. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Keppra Side Effects Report #5451869-3
KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Aug 27, 2007. Male patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aggression, attention deficit/hyperactivity disorder, dysarthria, grand mal convulsion, irritability, thrombocytopenia, . KEPPRA dosage: 1500 MG 2/D PO. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Dilantin Side Effects Report #5453116-5
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on Sept 05, 2007. Male patient, weighting 70.11 lb, was diagnosed with convulsion, streptococcal infection, hypertension and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: aspiration, attention deficit/hyperactivity disorder, corneal opacity, depression, dysphagia, emotional disorder, feeding disorder, gastrointestinal disorder, . DILANTIN dosage: unknown. During the same period patient was treated with AMPICILLIN, NORVASC. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Accutane Side Effects Report #5437598-0
ACCUTANE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 20, 2007. Male patient, 22 years of age, weighting 136.9 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: appendicitis, attention deficit/hyperactivity disorder, bipolar ii disorder, colitis, colitis ulcerative, crohn's disease, inflammatory bowel disease, intestinal obstruction, oesophagitis, . ACCUTANE dosage: unknown. Patient was hospitalized. Patient recovered.
ATTENTION DEFICIT/HYPERACTIVITY DISORDER : Strattera Side Effects Report #5383314-0
Physician from CANADA reported STRATTERA problem on June 27, 2007. Female patient, 13 years of age, weighting 160.0 lb, was diagnosed with mood altered and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: affective disorder, attention deficit/hyperactivity disorder, hepatic enzyme increased, pyrexia, rash, . STRATTERA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with LAMOTRIGINE. Patient was hospitalized. Patient recovered.